Status:
COMPLETED
Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a clinical study that is designed to study the effects of the supplemental intake of enriched omega-3 polyunsaturated fatty acids (fish oil) in patients with moderate to severe asthma. Some as...
Detailed Description
This study is a single-center, investigator-initiated, randomized, double-blind, placebo-controlled, cross-over trial. A total of 30 subjects will be recruited from the U.C. Davis Asthma Network (UCAN...
Eligibility Criteria
Inclusion
- Children and adults patients \>18 years or older with moderate and severe asthma (as diagnosed by lung specialist physician), based on the NIH NAEPP 1997 guidelines, who do not have an acute exacerbation at the time of enrollment and are on the same asthma medications for at least 1 month
Exclusion
- Less than 18 years of age
- Baseline FEV1 \< 35% predicted
- Known or suspected allergy to fish oil products
- Pregnant women and nursing women
- Current smokers or subjects with a 20 pack-year history of smoking
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00621829
Start Date
February 1 2008
End Date
October 1 2011
Last Update
May 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ucdmc/Vanchcs Ccrc
Mather, California, United States, 95655